Mechanisms of tamoxifen-induced apoptosis

Apoptosis

Volumn 6, Issue 6, 2001, Pages 469-477

  Mandlekar, S ^a   Kong, A N T ^b  

^a DUPONT COMPANY   (United States)

^b RUTGERS UNIVERSITY   (United States)

Author keywords

Apoptosis; Breast cancer; Caspases; Signal transduction; Tamoxifen

Indexed keywords

CALCIUM ION; CALMODULIN; CERAMIDE; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN CDC42; PROTEIN KINASE C; RAC PROTEIN; RAS PROTEIN; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; TAMOXIFEN; TRANSFORMING GROWTH FACTOR BETA;

APOPTOSIS; ARTICLE; BREAST CANCER; CALCIUM SIGNALING; CANCER CELL DESTRUCTION; CELL DEATH; ENZYME ACTIVATION; HUMAN; MEMBRANE PERMEABILITY; MITOCHONDRIAL MEMBRANE; NONHUMAN; ONCOGENE C MYC; OXIDATIVE STRESS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; ANTINEOPLASTIC AGENTS, HORMONAL; APOPTOSIS; BREAST NEOPLASMS; CALCIUM; CALMODULIN; CERAMIDES; FEMALE; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MAP KINASE KINASE 4; MAP KINASE SIGNALING SYSTEM; MITOCHONDRIA; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MODELS, BIOLOGICAL; OXIDATIVE STRESS; PROTEIN BINDING; PROTEIN KINASE C; PROTO-ONCOGENE PROTEINS C-MYC; RECEPTORS, ESTROGEN; SIGNAL TRANSDUCTION; TAMOXIFEN; TRANSFORMING GROWTH FACTOR BETA;

EID: 0035181465     PISSN: 13608185     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1012437607881     Document Type: Article

References (112)

1. The pharmacology and clinical uses of tamoxifen
2. Tamoxifen therapy in primary breast cancer: Biology, efficacy, and side effects
3. Tamoxifen. 'A big deal,' but a complex hand to play
4. Estrogen receptor alpha and estrogen receptor beta: Regulation by selective estrogen receptor modulators and importance in breast cancer
5. Molecular mechanisms of estrogen action: Selective ligands and receptor pharmacology
6. Role of proliferation and apoptosis in net growth rates of human breast cancer cells (MCF-7) treated with oestradiol and/or tamoxifen
7. Tamoxifen induction of apoptosis in estrogen receptor-negative cancers: New tricks for an old dog?
8. Effects of tamoxifen on growth and apoptosis of estrogen-dependent and -independent human breast cancer cells
9. Effect of tamoxifen on intraperitoneal N-nitroso-N-methylurea induced tumors
10. Tamoxifen induced apoptosis in ZR-75 breast cancer xenografts antedates turnout regression
11. Idoxifene antagonizes estradiol-dependent MCF-7 breast cancer xenograft growth through sustained induction of apoptosis
12. Pharmacodynamics of tamoxifen and its 4-hydroxy and N-desmethyl metabolites: Activation of caspases and induction of apoptosis in rat mammary tumors and in human breast cancer cell lines
13. Concentrations of tamoxifen and its major metabolites in hormone responsive and resistant breast tumours
14. Effective tamoxifen therapy of breast cancer involves both antiproliferative and pro-apoptotic changes
15. The expression of Ki-S1 and BCL-2 and the response to primary tamoxifen therapy in elderly patients with breast cancer
16. A comparative study of tamoxifen metabolism in female rat, mouse and human liver microsomes
17. Distribution of tamoxifen and its metabolites in rat and human tissues during steadystate treatment
18. Comparative binding affinities of tamoxifen, 4-hydroxytamoxifen, and desmethyltamoxifen for estrogen receptors isolated from human breast carcinoma: Correlation with blood levels in patients with metastatic breast cancer
19. Activation ofcaspase-3 and c-Jun NH2-terminal kinase-1 signaling pathways in tamoxifen-induced apoptosis of human breast cancer cells
20. The role of protein kinase C isoforms in cell proliferation and apoptosis
21. Inhibition of the membrane translocation and activation of protein kinase C, and potentiation of doxorubicin-induced apoptosis of hepatocellular carcinoma cells by tamoxifen
22. Specific and direct binding of protein kinase C to an immobilized tamoxifen analogue
23. Tamoxifen modulates protein kinase C via oxidative stress in estrogen receptor-negative breast cancer cells
24. Tamoxifen induces selective membrane association of protein kinase C epsilon in MCF-7 human breast cancer cells
25. Role of specific interactions between protein kinase C and triphenylethylenes in inhibition of the enzyme
26. Tamoxifen activates cellular phospholipase C and D and elicits protein kinase C translocation
27. Caspase-3-mediated cleavage of protein kinase C thera in induction of apoptosis
28. Proteolytic activation of protein kinase C delta by an ICE/CED 3-like protease induces characteristics of apoptosis
29. Mitochondrial translocation of protein kinase C delta in phorbol ester-induced cytochrome c release and apoptosis
30. Inhibition of protein kinase C mediated signal transduction by tamoxifen. Importance for antitumour activity
31. Inhibition of protein kinase C and calmodulin by the geometric isomers cis- and trans-tamoxifen
32. Calmodulin antagonism and growth-inhibiting activity of triphenylethylene antiestrogens in MCF-7 human breast cancer cells
33. Estrogen-induced activation of mitogenactivated protein kinase requires mobilization of intracellular calcium
34. Tamoxifen-induced enhancement of calcium signaling in glioma and MCF-7 breast cancer cells
35. Increase of ceramide and induction of mixed apoptosis/necrosis by N-(4-hydroxyphenyl)- retinamide in neuroblastoma cell lines
36. Ceramide signaling in apoptosis
37. The role of de novo ceramide synthesis in chemotherapy-induced apoptosis
38. Ordering of ceramide formation, caspase activation, and Bax/Bcl-2 expression during etoposide-induced apoptosis in C6 glioma cells
39. Phosphorylation of Raf by ceramide-activated protein kinase
40. Stress signals for apoptosis: Ceramide and c-Jun kinase
41. Inhibition of Akt kinase by cell-permeable ceramide and its implications for ceramide-induced apoptosis
42. Inhibition of PKB/Akt1 by C2-ceramide involves activation of ceramide-activated protein phosphatase in PC12 cells
43. Ceramide induces Bcl2 dephosphorylation via a mechanism involving mitochondrial PP2A
44. Agents that reverse multidrug resistance, tamoxifen, verapamil, and cyclosporin A, block glycosphingolipid metabolism by inhibiting ceramide glycosylation in human cancer cells
45. Role of c-myc in tamoxifen-induced apoptosis estrogen-independent breast cancer cells
46. Apoptosis induced by droloxifene and c-myc, bax and bcl-2 mRNA expression in cultured luteal cells of rats
47. Caspases and mitochondria in c-Myc-induced apoptosis: Identification of ATM as a new target of caspases
48. Involvement of CPP32/Caspase-3 in c-Myc-induced apoptosis
49. c-Myc plays a role in cellular susceptibility to death receptor-mediated and chemotherapy-induced apoptosis in human monocytic leukemia U937 cells
50. c-Myc-dependent hepatoma cell apoptosis results from oxidative stress and not a deficiency of growth factors
51. Induction of TNF-sensitive cellular phenotype by c-Myc involves p53 and impaired NF-kappaB activation
52. Mechanisms of apoptosis by c-Myc
53. c-Myc target genes involved in cell growth, apoptosis, and metabolism
54. Ornithine decarboxylase is a mediator of c-Myc-induced apoptosis
55. c-Myc transactivation of LDHA: Implications for tumor metabolism and growth
56. Participation of cyclin A in Myc-induced apoptosis
57. Requirement for the CD95 receptor-ligand pathway in c-Myc-induced apoptosis
58. Murine p38-delta mitogen-activated protein kinase, a developmentally regulated protein kinase that is activated by stress and proinflammatory cytokines
59. Cdc42 and PAK-mediated signaling leads to Jun kinase and p38 mitogen-activated protein kinase activation
60. Rho family GTPases regulate p38 mitogen-activated protein kinase through the downstream mediator Pak1
61. MEKKs, GCKs, MLKs, PAKs, TAKs, and tpls: Upstream regulators of the c-Jun amino-terminal kinases?
62. The p38 signal transduction pathway: Activation and function
63. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells
64. Differential regulation of mitogen-activated protein kinases by microtubule-binding agents in human breast cancer cells
65. A novel kinase cascade mediated by mitogen-activated protein kinase kinase 6 and MKK3
66. The role of c-Jun N-terminal kinase (JNK) in apoptosis induced by ultraviolet C and gamma radiation. Duration of JNK activation may determine cell death and proliferation
67. Phenethyl isothiocyanate, a natural chemopreventive agent, activates c-Jun N-terminal kinase 1
68. Molecular mechanisms of c-Jun N-terminal kinase-mediated apoptosis induced by anticarcinogenic isothiocyanates
69. Adriamycin activates c-jun N-terminal kinase in human leukemia cells: A relevance to apoptosis
70. The stress-activated protein kinase pathway mediates cell death following injury induced by cis-platinum, UV irradiation or heat
71. Tumor necrosis factor signaling to stress-activated protein kinase (SAPK)/Jun NH2-terminal kinase (JNK) and p38. Germinal center kinase couples TRAF2 to mitogen-activated protein kinase/ERK kinase kinase 1 and SAPK while receptor interacting protein associates with a mitogen-activated protein kinase upstream of MKK6 and p38
72. Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain
73. Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways
74. Stress-induced phosphorylation and activation of the transcription factor CHOP (GADD 153) by p38 MAP kinase
75. Mitogen- and stress-activated protein kinase- 1 (MSK1) is directly activated by MAPK and SAPK2/p38, and may mediate activation of CREB
76. Activation of the p38 mitogenactivated protein kinase pathway by estrogen or by 4-hydroxytamoxifen is coupled to estrogen receptor-induced apoptosis
77. Mammalian caspases: Structure, activation, substrates, and functions during apoptosis
78. Caspases: Key mediators of apoptosis
79. Caspases: The executioners of apoptosis
80. Apoptosis control by death and decoy receptors
81. Common regulation of apoptosis signaling induced by CD95 and the DNA-damaging stimuli etoposide and gamma-radiation downstream from caspase-8 activation
82. The CD95 (APO-1/Fas) system mediates drug-induced apoptosis in neuroblastoma cells
83. Activation of mitochondria and release of mitochondrial apoptogenic factors by betulinic acid
84. Fas ligand-independent, FADD-mediated activation of the Fas death pathway by anticancer drugs
85. Anticancer drugs induce caspase-8/FLICE activation and apoptosis in the absence of CD95 receptor/ligand interaction
86. Superoxide radical-initiated apoptotic signalling pathway in selenitetreated HepG(2) cells: Mitochondria serve as the main target
87. Arsenite induces apoptosis via a direct effect on the mitochondrial permeability transition pore
88. Cytochrome c-dependent and -independent induction of apoptosis in multiple myeloma cells
89. Caspase-dependent cleavage of nucleic acids
90. Death by a thousand cuts: An ever increasing list of caspase substrates
91. Specific cleavage of the 70-kDa protein component of the U1 small nuclear ribonucleoprotein is a characteristic biochemical feature of apoptotic cell death
92. DNA-dependent protein kinase is one of a subset of autoantigens specifically cleaved early during apoptosis
93. Caspases disrupt the nuclearcytoplasmic barrier
94. p53-independent dephosphorylation and cleavage of retinoblastoma protein during tamoxifen-induced apoptosis in human breast carcinoma cells
95. Mitochondrial permeability transition in apoptosis and necrosis
96. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade
97. An APAF-1.cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9
98. Effects of tamoxifen on the electron transport chain of isolated rat liver mitochondria
99. Tamoxifen but not 4-hydroxytamoxifen initiates apoptosis in p53(-) normal human mammary epithelial cells by inducing mitochondrial depolarization
100. Hematopoietic progenitor kinase 1 is a component of transforming growth factor beta-induced c-Jun N-terminal kinase signaling cascade
101. Induction of transforming growth factor beta 1 in human breast cancer in vivo following tamoxifen treatment
102. Transforming growth factor beta secretion from primary breast cancer fibroblasts
103. Blockade of transforming growth factor-beta signaling does not abrogate antiestrogen-induced growth inhibition of human breast carcinoma cells
104. Relationship between tamoxifen-induced transforming growth factor beta 1 expression, cytostasis and apoptosis in human breast cancer cells
105. Anti-oestrogens induce the secretion of active transforming growth factor beta from human fetal fibroblasts
106. Tamoxifen induces TGF-beta 1 activity and apoptosis of human MCF-7 breast cancer cells in vitro
107. Tamoxifen and hydroxytamoxifen as intramembraneous inhibitors of lipid peroxidation. Evidence for peroxyl radical scavenging activity
108. Tamoxifen inhibits induction of the mitochondrial permeability transition by Ca2 + and inorganic phosphate
109. Tamoxifen enhances myoepithelial cell suppression of human breast carcinoma progression in vitro by two different effector mechanisms
110. Regulation of fas ligand expression in breast cancer cells by estrogen: Functional differences between estradiol and tamoxifen
111. Tamoxifen interferes with the insulin-like growth factor I receptor (IGF-IR) signaling pathway in breast cancer cells
112. Alternative mechanisms of action of anti-oestrogens